Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00162370
Status:
COMPLETED
Last Update Posted:
2021-03-15
First Post:
2005-09-09
Brief Title:
A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease
Sponsor:
Lantheus Medical Imaging
Organization:
Lantheus Medical Imaging
Study Overview
Official Title:
SMART Stress Echocardiography in Menopausal Women at Risk for Coronary Artery Disease Trial
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is designed to see if stress echocardiography can be used as a screening exam in peri- or post-menopausal women with a risk of developing of coronary artery disease and experiencing future cardiac events
Detailed Description:
The clinical trial is designed to determine the prognostic value of stress echocardiography as a screening examination in peri- or post-menopausal female patients with an intermediate likelihood of coronary artery disease CAD based on risk factors to identify patients at higher risk of experiencing future cardiac eventsFemale patients who are able to adequately exercise will undergo a symptom-limited exercise echocardiogram Patients who are unable to adequately exercise or are predicted to be unable to exercise adequately because of orthopedicneurologic limitations lung disease or debility will perform dobutamine stress echocardiography All patients will receive DEFINITY at rest and stress to enhance wall motion assessment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None